{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:59:31Z","timestamp":1778075971792,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T00:00:00Z","timestamp":1703980800000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jaut.2022.102980","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T01:08:50Z","timestamp":1671152930000},"page":"102980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Comprehensive description of adult-onset Still's disease after COVID-19 vaccination"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2717-9437","authenticated-orcid":false,"given":"Pascale","family":"Palassin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Bres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaher","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ange","family":"Alfonsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Massy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Gras-Champel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Thibault Jacques","family":"Maria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Faillie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2022.102980_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.therap.2021.05.003","article-title":"French organization for the pharmacovigilance of COVID-19 vaccines: a major challenge","volume":"76","author":"Lacroix","year":"2021","journal-title":"Therapie"},{"key":"10.1016\/j.jaut.2022.102980_bib3","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2022.102980_bib4","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA covid-19 vaccine in a nationwide setting","volume":"385","author":"Barda","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2022.102980_bib5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.jaut.2022.102980_bib6","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10067-022-06149-4","article-title":"Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune\/inflammatory syndrome expand?","volume":"41","author":"Jara","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102980_bib7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41563-020-0746-0","article-title":"Next-generation vaccine platforms for COVID-19","volume":"19","author":"van Riel","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jaut.2022.102980_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still's disease","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2022.102980_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2014.01.011","article-title":"Diagnosis and classification of adult Still's disease","volume":"48\u201349","author":"Mahroum","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2022.102980_bib10","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102980_bib11","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1016\/S2665-9913(21)00072-2","article-title":"First manifestation of adult-onset Still's disease after COVID-19","volume":"3","author":"Bamidis","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaut.2022.102980_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/1179547621996306","article-title":"Diagnosis of adult onset Still's disease in a patient who has recovered from coronavirus-19","volume":"14","author":"Alshablan","year":"2021","journal-title":"Clin. Med. Insights Case Rep."},{"key":"10.1016\/j.jaut.2022.102980_bib13","first-page":"2049","article-title":"Risk factors for adult Still's disease","volume":"23","author":"Sampalis","year":"1996","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102980_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pds.668","article-title":"A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions","volume":"11","author":"van Puijenbroek","year":"2002","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jaut.2022.102980_bib15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset still disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2022.102980_bib16","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s10067-022-06124-z","article-title":"Two flares of Still's disease after two doses of the ChAdOx1 vaccine","volume":"41","author":"Roongta","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102980_bib17","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1016\/S2665-9913(21)00218-6","article-title":"Adult-onset Still's disease following COVID-19 vaccination","volume":"3","author":"Leone","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"Suppl 132","key":"10.1016\/j.jaut.2022.102980_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.55563\/clinexprheumatol\/tvlpnc","article-title":"Flare-up of adult-onset Still's disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine","volume":"39","author":"Yamamoto","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102980_bib48","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00296-021-05052-6","article-title":"A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient","volume":"42","author":"Jeon","year":"2022","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2022.102980_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2478\/rjim-2021-0035","article-title":"Hyper-inflammation after COVID-19 mARN vaccination: at the crossroads of multisystem inflammatory disease and adult-onset Still's disease. Does terminology matter?","volume":"60","author":"Baicus","year":"2022","journal-title":"Romanian J. Intern. Med. Rev. Roum. Med. Interne"},{"key":"10.1016\/j.jaut.2022.102980_bib50","article-title":"Adult-onset Still's disease following mRNA COVID-19 vaccination","volume":"233","author":"Sharabi","year":"2021","journal-title":"Clin. Immunol. Orlando Fla"},{"key":"10.1016\/j.jaut.2022.102980_bib51","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1016\/S2665-9913(21)00219-8","article-title":"Adult-onset Still's disease after mRNA COVID-19 vaccine","volume":"3","author":"Magliulo","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaut.2022.102980_bib52","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.3346\/jkms.2021.36.e344","article-title":"Adult-onset Still's disease after BNT162b2 mRNA COVID-19 vaccine","volume":"36","author":"Park","year":"2021","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.jaut.2022.102980_bib53","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s10067-022-06106-1","article-title":"Flare of adult-onset Still's disease following mRNA COVID-19 vaccination: a case report and review of literature","volume":"41","author":"Kim","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102980_bib54","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s41927-021-00237-9","article-title":"Macrophage activation syndrome in a patient with adult-onset Still's disease following first COVID-19 vaccination with BNT162b2","volume":"5","author":"Muench","year":"2021","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.jaut.2022.102980_bib55","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s10067-022-06065-7","article-title":"New-onset Adult-onset Still's disease-like syndrome after ChAdOx1 nCoV-19 vaccination-a case series with review of literature","volume":"41","author":"Padiyar","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102980_bib56","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1111\/imj.15563","article-title":"Adult\u2010onset Still disease post\u2010adenovirus vector COVID \u201019 vaccine","volume":"51","author":"Sweeney","year":"2021","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.jaut.2022.102980_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.therap.2020.02.012","article-title":"Pharmacovigilance and drug-induced rare diseases: strengths of the French network of regional pharmacovigilance centres","volume":"75","author":"Lacroix","year":"2020","journal-title":"Therapie"},{"key":"10.1016\/j.jaut.2022.102980_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102898","article-title":"Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review","volume":"132","author":"Rodr\u00edguez","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2022.102980_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102778","article-title":"Ferritin - from iron, through inflammation and autoimmunity, to COVID-19","volume":"126","author":"Mahroum","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2022.102980_bib21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/cmi.2017.151","article-title":"Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction","volume":"15","author":"Segal","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jaut.2022.102980_bib22","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/1040841X.2019.1614904","article-title":"The role of viral infections in the development of autoimmune diseases","volume":"45","author":"Hussein","year":"2019","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.jaut.2022.102980_bib23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"ASIA\u201d - autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2022.102980_bib24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrrheum.2009.196","article-title":"Vaccines and autoimmunity","volume":"5","author":"Agmon-Levin","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102980_bib25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jaut.2022.102980_bib26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset Still's disease","volume":"14","author":"Feist","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102980_bib27","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2022.102980_bib28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jbspin.2010.03.017","article-title":"Adult onset Still's disease following influenza vaccination","volume":"77","author":"Yoo","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jaut.2022.102980_bib29","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3109\/s10165-011-0418-7","article-title":"Onset of adult-onset Still's disease following influenza vaccination","volume":"21","author":"Yoshioka","year":"2011","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2022.102980_bib30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1684\/ejd.2021.4102","article-title":"Adult-onset Still\u2019s disease following pneumococcal vaccination","volume":"31","author":"Sato","year":"2021","journal-title":"Eur. J. Dermatol. EJD"},{"key":"10.1016\/j.jaut.2022.102980_bib31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0248-8663(97)83425-X","article-title":"[Adult-onset Still's disease after hepatitis A and B vaccination?]","volume":"19","author":"Grasland","year":"1998","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.jaut.2022.102980_bib32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1056\/NEJMcibr2113694","article-title":"A possible role for anti-idiotype antibodies in SARS-CoV-2 infection and vaccination. Hamel MB","volume":"386","author":"Murphy","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2022.102980_bib33","first-page":"373","article-title":"Towards a network theory of the immune system","volume":"125C","author":"Jerne","year":"1974","journal-title":"Ann. Immunol."},{"key":"10.1016\/j.jaut.2022.102980_bib34","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","article-title":"SARS-CoV-2 spike protein interacts with and activates TLR41","volume":"31","author":"Zhao","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.jaut.2022.102980_bib35","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68563","article-title":"SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-\u03baB pathway","volume":"10","author":"Khan","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jaut.2022.102980_bib36","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3389\/fimmu.2019.00594","article-title":"Advances in mRNA vaccines for infectious diseases","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2022.102980_bib37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2022.102980_bib38","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2022.102980_bib39","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3390\/vaccines10071022","article-title":"Adult-onset Still's disease-like syndrome following COVID-19 vaccination: a case report and review of the literature","volume":"10","author":"Winichakoon","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.jaut.2022.102980_bib40","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jaut.2022.102980_bib41","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jama.2021.13443","article-title":"Myocarditis and pericarditis after vaccination for COVID-19","volume":"326","author":"Diaz","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jaut.2022.102980_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102541","article-title":"Cardiac involvement in adult-onset Still's disease: manifestations, treatments and outcomes in a retrospective study of 28 patients","volume":"116","author":"Bodard","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2022.102980_bib43","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1586\/1744666X.2014.962996","article-title":"Methotrexate: an old new drug in autoimmune disease","volume":"10","author":"Cipriani","year":"2014","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2022.102980_bib44","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/S2665-9913(21)00012-6","article-title":"Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study","volume":"3","author":"Cavalli","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaut.2022.102980_bib45","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","article-title":"Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions","volume":"13","author":"Maria","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2022.102980_bib46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.therap.2017.08.006","article-title":"[Case-non case studies: principles, methods, bias and interpretation]","volume":"73","author":"Faillie","year":"2018","journal-title":"Therapie"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:31:59Z","timestamp":1760257919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841122001883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":55,"alternative-id":["S0896841122001883"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102980","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive description of adult-onset Still's disease after COVID-19 vaccination","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102980","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102980"}}